Lantheus Q2 revenue up 2.7% to $388.2 million; guidance suspended amid Curium deal
Lantheus reported second quarter 2026 revenue of $388.2 million, up 2.7% from a year earlier, while GAAP diluted earnings per share were $1.11 versus $1.12 and adjusted diluted earnings per share were $1.55 versus $1.57. The company suspended its full year 2026 guidance and will not hold a conference call, citing the pending merger with Curium announced August 3, 2026, under which shareholders would receive $102.50 per share in cash plus contingent value rights worth up to $12.00 per share.
Key points
- Worldwide revenue of $388.2 million, up 2.7%; PYLARIFY sales of $240.4 million, down 4.1%
- GAAP net income of $75.0 million, down 4.7%; adjusted net income of $104.9 million, down 5.1%
- Full year 2026 guidance suspended in connection with the pending transaction
- Merger consideration of $102.50 per share in cash plus CVRs of up to $12.00 per share; total transaction value of up to approximately $8.0 billion
The filing
Written by AI on Nov 8, 2026, 12:57 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on August 06, 2026.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.